Literature DB >> 15215251

Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells.

Haiyan Jia1, Azadeh Bagherzadeh, Roy Bicknell, Michael R Duchen, Dan Liu, Ian Zachary.   

Abstract

Vascular endothelial growth factor (VEGF)-D binds to VEGF receptors (VEGFR) VEGFR2/KDR and VEGFR3/Flt4, but the signaling mechanisms mediating its biological activities in endothelial cells are poorly understood. Here we investigated the mechanism of action of VEGF-D, and we compared the signaling pathways and biological responses induced by VEGF-D and VEGF-A in endothelial cells. VEGF-D induced KDR and phospholipase C-gamma tyrosine phosphorylation more slowly and less effectively than VEGF-A at early times but had a more sustained effect and was as effective as VEGF-A after 60 min. VEGF-D activated extracellular signal-regulated protein kinases 1 and 2 with similar efficacy but slower kinetics compared with VEGF-A, and this effect was blocked by inhibitors of protein kinase C and mitogen-activated protein kinase kinase. In contrast to VEGF-A, VEGF-D weakly stimulated prostacyclin production and gene expression, had little effect on cell proliferation, and stimulated a smaller and more transient increase in intracellular [Ca(2+)]. VEGF-D induced strong but more transient phosphatidylinositol 3-kinase (PI3K)-mediated Akt activation and increased PI3K-dependent endothelial nitric-oxide synthase phosphorylation and cell survival more weakly. VEGF-D stimulated chemotaxis via a PI3K/Akt- and endothelial nitric-oxide synthase-dependent pathway, enhanced protein kinase C- and PI3K-dependent endothelial tubulogenesis, and stimulated angiogenesis in a mouse sponge implant model less effectively than VEGF-A. VEGF-D-induced signaling and biological effects were blocked by the KDR inhibitor SU5614. The finding that differential KDR activation by VEGF-A and VEGF-D has distinct consequences for endothelial signaling and function has important implications for understanding how multiple ligands for the same VEGF receptors can generate ligand-specific biological responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215251     DOI: 10.1074/jbc.M401538200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Expression of VEGFR3 in glioma endothelium correlates with tumor grade.

Authors:  S J Grau; F Trillsch; J Herms; N Thon; P J Nelson; J-C Tonn; R Goldbrunner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

2.  Interleukin-1 beta increases activity of human endothelial progenitor cells: involvement of PI3K-Akt signaling pathway.

Authors:  Lin Yang; Xiao-Gang Guo; Chang-Qing Du; Jin-Xiu Yang; Dong-Mei Jiang; Bo Li; Wen-Jing Zhou; Fu-Rong Zhang
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

Review 3.  Noncanonical activity of seryl-transfer RNA synthetase and vascular development.

Authors:  Atsuo Kawahara; Didier Y R Stainier
Journal:  Trends Cardiovasc Med       Date:  2009-08       Impact factor: 6.677

4.  Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue.

Authors:  Sarah Tzu-Feng Hsiao; Azar Asgari; Zerina Lokmic; Rodney Sinclair; Gregory James Dusting; Shiang Yong Lim; Rodney James Dilley
Journal:  Stem Cells Dev       Date:  2012-02-03       Impact factor: 3.272

5.  Fluid shear promotes chondrosarcoma cell invasion by activating matrix metalloproteinase 12 via IGF-2 and VEGF signaling pathways.

Authors:  P Wang; S-H Chen; W-C Hung; C Paul; F Zhu; P-P Guan; D L Huso; A Kontrogianni-Konstantopoulos; K Konstantopoulos
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

6.  Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting.

Authors:  Resham Bhattacharya; Junhye Kwon; Xiujuan Li; Enfeng Wang; Sujata Patra; John Paul Bida; Zeljko Bajzer; Lena Claesson-Welsh; Debabrata Mukhopadhyay
Journal:  J Cell Sci       Date:  2009-04-01       Impact factor: 5.285

7.  Comparison of Efficiency and Function of Vascular Endothelial Growth Factor Adenovirus Vectors in Endothelial Cells for Gene Therapy of Placental Insufficiency.

Authors:  Carlo Rossi; Mark Lees; Vedanta Mehta; Tommi Heikura; John Martin; Ian Zachary; Rebecca Spencer; Donald M Peebles; Robert Shaw; Minna Karhinen; Seppo Yla-Herttuala; Anna L David
Journal:  Hum Gene Ther       Date:  2020-11       Impact factor: 5.695

8.  Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells.

Authors:  Charles L Stebbins; James P Stice; C Michael Hart; Fiona N Mbai; Anne A Knowlton
Journal:  J Cardiovasc Pharmacol Ther       Date:  2008-08-05       Impact factor: 2.457

9.  Noncanonical activity of seryl-tRNA synthetase is involved in vascular development.

Authors:  Hajime Fukui; Ryuki Hanaoka; Atsuo Kawahara
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

10.  Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity.

Authors:  H Jia; L Cheng; M Tickner; A Bagherzadeh; D Selwood; I Zachary
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.